Cargando…
Molecular Targets in Alzheimer's Disease: From Pathogenesis to Therapeutics
Alzheimer's disease (AD) is characterized by progressive cognitive decline usually beginning with impairment in the ability to form recent memories. Nonavailability of definitive therapeutic strategy urges developing pharmacological targets based on cell signaling pathways. A great revival of i...
Autores principales: | Cheng, Xuan, Zhang, Lu, Lian, Ya-Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4668300/ https://www.ncbi.nlm.nih.gov/pubmed/26665008 http://dx.doi.org/10.1155/2015/760758 |
Ejemplares similares
-
Alzheimer’s disease: pathogenesis, diagnostics, and therapeutics
por: Tiwari, Sneham, et al.
Publicado: (2019) -
Apoe4 and Alzheimer’s Disease Pathogenesis—Mitochondrial Deregulation and Targeted Therapeutic Strategies
por: Pires, Mariana, et al.
Publicado: (2023) -
Diverse Molecular Targets for Therapeutic Strategies in Alzheimer's Disease
por: Han, Sun-Ho, et al.
Publicado: (2014) -
Iron and Alzheimer’s Disease: From Pathogenesis to Therapeutic Implications
por: Liu, Jun-Lin, et al.
Publicado: (2018) -
Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease
por: Guo, Tiantian, et al.
Publicado: (2020)